France
· Delayed Price · Currency is EUR Global Bioenergies Statistics
Total Valuation
EPA:ALGBE has a market cap or net worth of EUR 26.86 million. The enterprise value is 35.09 million.
| Market Cap | 26.86M |
| Enterprise Value | 35.09M |
Important Dates
The next estimated earnings date is Tuesday, February 25, 2025.
| Earnings Date | Feb 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
EPA:ALGBE has 18.13 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 18.13M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.58% |
| Owned by Institutions (%) | 3.65% |
| Float | 15.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.99 |
| EV / Sales | 7.48 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.16
| Current Ratio | 4.16 |
| Quick Ratio | 3.81 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -251.27% and return on invested capital (ROIC) is -37.34%.
| Return on Equity (ROE) | -251.27% |
| Return on Assets (ROA) | -30.21% |
| Return on Invested Capital (ROIC) | -37.34% |
| Return on Capital Employed (ROCE) | -89.31% |
| Revenue Per Employee | 106,636 |
| Profits Per Employee | -133,205 |
| Employee Count | 46 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 3.76 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.81% in the last 52 weeks. The beta is 1.74, so EPA:ALGBE's price volatility has been higher than the market average.
| Beta (5Y) | 1.74 |
| 52-Week Price Change | -22.81% |
| 50-Day Moving Average | 1.11 |
| 200-Day Moving Average | 1.38 |
| Relative Strength Index (RSI) | 65.00 |
| Average Volume (20 Days) | 41,618 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EPA:ALGBE had revenue of EUR 4.69 million and -5.86 million in losses.
| Revenue | 4.69M |
| Gross Profit | 2.87M |
| Operating Income | -6.74M |
| Pretax Income | -7.11M |
| Net Income | -5.86M |
| EBITDA | -5.22M |
| EBIT | -6.74M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 4.86 million in cash and 13.09 million in debt, giving a net cash position of -8.23 million or -0.45 per share.
| Cash & Cash Equivalents | 4.86M |
| Total Debt | 13.09M |
| Net Cash | -8.23M |
| Net Cash Per Share | -0.45 |
| Equity (Book Value) | -5.74M |
| Book Value Per Share | n/a |
| Working Capital | 6.65M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 61.08%, with operating and profit margins of -143.73% and -124.91%.
| Gross Margin | 61.08% |
| Operating Margin | -143.73% |
| Pretax Margin | -151.58% |
| Profit Margin | -124.91% |
| EBITDA Margin | -111.30% |
| EBIT Margin | -143.73% |
| FCF Margin | n/a |
Dividends & Yields
EPA:ALGBE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -21.82% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
EPA:ALGBE has an Altman Z-Score of -0.85. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.85 |
| Piotroski F-Score | n/a |